Drug Discovery Stocks List

Recent Signals

Date Stock Signal Type
2020-08-07 ADPT 180 Bearish Setup Bearish Swing Setup
2020-08-07 ADPT Fell Below 20 DMA Bearish
2020-08-07 BASI 50 DMA Support Bullish
2020-08-07 BASI 20 DMA Support Bullish
2020-08-07 BBC 20 DMA Resistance Bearish
2020-08-07 BLFS Pocket Pivot Bullish Swing Setup
2020-08-07 BLRX MACD Bearish Signal Line Cross Bearish
2020-08-07 BLRX Crossed Above 20 DMA Bullish
2020-08-07 BLRX Crossed Above 200 DMA Bullish
2020-08-07 BMRN Fell Below 50 DMA Bearish
2020-08-07 BNTX Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2020-08-07 BNTX Doji - Bullish? Reversal
2020-08-07 BNTX 1,2,3 Pullback Bullish Bullish Swing Setup
2020-08-07 CLVS Expansion Breakdown Bearish Swing Setup
2020-08-07 CLVS MACD Bearish Signal Line Cross Bearish
2020-08-07 CRIS Pocket Pivot Bullish Swing Setup
2020-08-07 CRL Pocket Pivot Bullish Swing Setup
2020-08-07 CRL New 52 Week Closing High Bullish
2020-08-07 CRL Upper Bollinger Band Walk Strength
2020-08-07 CRL New 52 Week High Strength
2020-08-07 GE Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2020-08-07 GLW Slingshot Bullish Bullish Swing Setup
2020-08-07 GLYC NR7-2 Range Contraction
2020-08-07 GLYC NR7 Range Contraction
2020-08-07 HCM NR7-2 Range Contraction
2020-08-07 HCM Upper Bollinger Band Walk Strength
2020-08-07 HCM Slingshot Bullish Bullish Swing Setup
2020-08-07 HCM NR7 Range Contraction
2020-08-07 HTGC Slingshot Bullish Bullish Swing Setup
2020-08-07 HTGC Stochastic Sell Signal Bearish
2020-08-07 HTGC Upper Bollinger Band Walk Strength
2020-08-07 IDYA Crossed Above 50 DMA Bullish
2020-08-07 IDYA 20 DMA Resistance Bearish
2020-08-07 IEX 20 DMA Support Bullish
2020-08-07 IEX Bollinger Band Squeeze Range Contraction
2020-08-07 INFI Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2020-08-07 INFI NR7 Range Contraction
2020-08-07 INFI Narrow Range Bar Range Contraction
2020-08-07 IONS Lower Bollinger Band Walk Weakness
2020-08-07 IONS Stochastic Reached Oversold Weakness
2020-08-07 LMNL Calm After Storm Range Contraction
2020-08-07 LMNL Narrow Range Bar Range Contraction
2020-08-07 LMNL Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2020-08-07 LMNL NR7 Range Contraction
2020-08-07 LMNL 1,2,3 Pullback Bullish Bullish Swing Setup
2020-08-07 LRMR Bollinger Band Squeeze Range Contraction
2020-08-07 LRMR Stochastic Reached Oversold Weakness
2020-08-07 LRMR 180 Bearish Setup Bearish Swing Setup
2020-08-07 LRMR Lower Bollinger Band Walk Weakness
2020-08-07 LXRX 1,2,3 Pullback Bullish Bullish Swing Setup
2020-08-07 LXRX Calm After Storm Range Contraction
2020-08-07 MREO 50 DMA Resistance Bearish
2020-08-07 MREO 1,2,3 Pullback Bullish Bullish Swing Setup
2020-08-07 PKI Narrow Range Bar Range Contraction
2020-08-07 PKI NR7 Range Contraction
2020-08-07 PRTA 20 DMA Support Bullish
2020-08-07 PRTA Bollinger Band Squeeze Range Contraction
2020-08-07 RLAY Lizard Bearish Bearish Day Trade Setup
2020-08-07 RLAY Shooting Star Candlestick Bearish
2020-08-07 RLAY Doji - Bearish? Reversal
2020-08-07 SDGR NR7 Range Contraction
2020-08-07 SMMT NR7 Range Contraction
2020-08-07 SMMT Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2020-08-07 SMMT Bollinger Band Squeeze Range Contraction
2020-08-07 SMMT Narrow Range Bar Range Contraction
2020-08-07 STRO Bollinger Band Squeeze Range Contraction
2020-08-07 STRO Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2020-08-07 TPVY Upper Bollinger Band Walk Strength
2020-08-07 TWST Upper Bollinger Band Walk Strength
2020-08-07 TWST Wide Range Bar Range Expansion
2020-08-07 TWST New 52 Week High Strength
2020-08-07 UMRX Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2020-08-07 UMRX Pocket Pivot Bullish Swing Setup
2020-08-07 UMRX 1,2,3 Pullback Bullish Bullish Swing Setup
2020-08-07 UMRX 20 DMA Resistance Bearish
2020-08-07 VTGN Volume Surge Other
2020-08-07 VTGN Golden Cross Bullish
2020-08-07 VTGN Pocket Pivot Bullish Swing Setup
2020-08-07 WAT Bullish Engulfing Bullish
2020-08-07 WAT Stochastic Buy Signal Bullish

In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered. Historically, drugs were discovered through identifying the active ingredient from traditional remedies or by serendipitous discovery. Later chemical libraries of synthetic small molecules, natural products or extracts were screened in intact cells or whole organisms to identify substances that have a desirable therapeutic effect in a process known as
classical pharmacology. Since sequencing of the human genome which allowed rapid cloning and synthesis of large quantities of purified proteins, it has become common practice to use high throughput screening of large compounds libraries against isolated biological targets which are hypothesized to be disease modifying in a process known as reverse pharmacology. Hits from these screens are then tested in cells and then in animals for efficacy.
Modern drug discovery involves the identification of screening hits, medicinal chemistry and optimization of those hits to increase the affinity, selectivity (to reduce the potential of side effects), efficacy/potency, metabolic stability (to increase the half-life), and oral bioavailability. Once a compound that fulfills all of these requirements has been identified, it will begin the process of drug development prior to clinical trials. One or more of these steps may, but not necessarily, involve computer-aided drug design. Modern drug discovery is thus usually a capital-intensive process that involves large investments by pharmaceutical industry corporations as well as national governments (who provide grants and loan guarantees). Despite advances in technology and understanding of biological systems, drug discovery is still a lengthy, "expensive, difficult, and inefficient process" with low rate of new therapeutic discovery. In 2010, the research and development cost of each new molecular entity was about US$1.8 billion. Drug discovery is done by pharmaceutical companies, with research assistance from universities. The "final product" of drug discovery is a patent on the potential drug. The drug requires very expensive Phase I, II and III clinical trials, and most of them fail. Small companies have a critical role, often then selling the rights to larger companies that have the resources to run the clinical trials.
Discovering drugs that may be a commercial success, or a public health success, involves a complex interaction between investors, industry, academia, patent laws, regulatory exclusivity, marketing and the need to balance secrecy with communication. Meanwhile, for disorders whose rarity means that no large commercial success or public health effect can be expected, the orphan drug funding process ensures that people who experience those disorders can have some hope of pharmacotherapeutic advances.

More about Drug Discovery